TR-FRET-Based Duplex Immunoassay Reveals an Inverse Correlation of Soluble and Aggregated Mutant huntingtin in Huntington's Disease

  • Barbara Baldo
  • , Paolo Paganetti
  • , Stephan Grueninger
  • , David Marcellin
  • , Linda S. Kaltenbach
  • , Donald C. Lo
  • , Martin Semmelroth
  • , Andjelija Zivanovic
  • , Dorothee Abramowski
  • , Donna Smith
  • , Gregor P. Lotz
  • , Gillian P. Bates
  • , Andreas Weiss

Research output: Contribution to journalArticlepeer-review

65 Citations (Scopus)

Abstract

Huntington's disease (HD) is an inherited neurodegenerative disorder caused by the amplification of a polyglutamine stretch at the N terminus of the huntingtin protein. N-terminal fragments of the mutant huntingtin (mHtt) aggregate and form intracellular inclusions in brain and peripheral tissues. Aggregates are an important hallmark of the disease, translating into a high need to quantify them in vitro and in vivo. We developed a one-step TR-FRET-based immunoassay to quantify soluble and aggregated mHtt in cell and tissue homogenates. Strikingly, quantification revealed a decrease of soluble mHtt correlating with an increase of aggregated protein in primary neuronal cell cultures, transgenic R6/2, and HdhQ150 knock-in HD mice. These results emphasize the assay's efficiency for highly sensitive and quantitative detection of soluble and aggregated mHtt and its application in high-throughput screening and characterization of HD models.
Original languageEnglish
Pages (from-to)264 - 275
Number of pages12
JournalChemistry and Biology
Volume19
Issue number2
DOIs
Publication statusPublished - 24 Feb 2012

Fingerprint

Dive into the research topics of 'TR-FRET-Based Duplex Immunoassay Reveals an Inverse Correlation of Soluble and Aggregated Mutant huntingtin in Huntington's Disease'. Together they form a unique fingerprint.

Cite this